Chemours conducts first amendment for increased credit facility

Chicago, Oct. 8 – Chemours Co. entered into a first amendment with JPMorgan Chase Bank, NA as administrative agent to the amended and restated credit agreement from April 3, 2018, according to an 8-K filing with the Securities and Exchange Commission.

The amendment, signed Oct. 7, increases the revolver to $900 million, up $100 million, and moves the maturity date to Oct. 7, 2026 from April 3, 2023.

The maturity date could be modified in the event of a springing maturity instrument event.

JPMorgan Chase Bank, NA, Citibank, NA, Bank of America, NA, Credit Suisse AG, Royal Bank of Canada, Goldman Sachs Bank USA, Toronto-Dominion Bank, New York Branch and Deutsche Bank AG New York Branch are listed as lenders.

Chemours is a Wilmington, Del.-based provider of performance chemicals.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.